Skip to main content
. 2023 Aug 3;12(17):17559–17568. doi: 10.1002/cam4.6369

TABLE 1.

Tumor responses based on RECIST 1.1.

Response All patients (n = 184) First‐line patients (n = 119) Later line patients (n = 65) p value
Objective response rate 55 (29.9%) 45 (37.8%) 10 (15.4%) 0.0020
Disease control rate 131 (71.2%) 99 (83.2%) 32 (49.2%) <0.001
Complete response 4 (2.2%) 3 (2.5%) 1 (1.5%) NS
Partial response 51 (27.7%) 42 (35.3%) 9 (13.8%) <0.001
Stable disease 76 (41.3%) 54 (45.4%) 22 (33.8%) <0.001
Progressive disease 53 (28.8%) 20 (16.8%) 33 (50.8%) NS

Abbreviation: NS, not significant.